Search
for
Sort by
Research 61–90 of 103
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Therapeutics for COVID-19 and post COVID-19 complications: An update
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- New and Emerging Therapies for Alopecia Areata
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- JAK 1-3 inhibitors and TYK-2 inhibitors in dermatology: Practical pearls for the primary care physician
- Baricitinib for the Treatment of Alopecia Areata
- Comparison of efficacy and safety of tofacitinib and azathioprine in patients with alopecia areata and variants: a double-blind, randomized controlled trial
- Selective Janus kinase 1 inhibition resolves inflammation and restores hair growth offering a viable treatment option for alopecia areata
- The Importance of Readability: A Guide to Understanding Alopecia Areata through Multilingual Online Resources
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Design and Characterization of Baricitinib Incorporated PLA 3D Printed Pills by Fused Deposition Modeling: An Oral Pill for Treating Alopecia Areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review
- Treatments for Moderate-to-Severe Alopecia Areata: A Systematic Narrative Review
- Alopecia Areata: Burden of Disease, Approach to Treatment, and Current Unmet Needs
- Alopecia areata: A clinical review of the changing landscape with Janus kinase inhibitors
- Clinical Efficacy and Safety of Baricitinib in Patients With Alopecia Areata in Korea
- Dermatologists’ Perspectives and Real-World Assessment of Alopecia Areata Severity, Burden, and Healthcare Resource Utilization in Adults in the United Arab Emirates
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Assessing Alopecia Areata Management in Poland: Challenges in Medical Practices and Patient Care
- Alopecia areata: current concepts
- Exploring novel management options for alopecia areata
- The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden
- Off-Label Treatment of Alopecia Areata—Retrospective Study
- Evaluating Current and Emergent JAK Inhibitors for Alopecia Areata: A Narrative Review
- Rates of Infections, Malignancies, Cardiovascular Outcomes, and Death in Individuals with Hospital-treated Alopecia Areata: A Registry-based Cohort Study in Denmark
- Real-world Effectiveness and Safety of Janus Kinase Inhibitors in Alopecia Areata: A Retrospective Cohort Study of 72 Patients
- Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities
- Characteristics and Management of Patients with Alopecia Areata and Selected Comorbid Conditions: Results from a Survey in Five European Countries
- Diagnosis and Management of Alopecia Areata: A Saudi Expert Consensus Statement (2023)